High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre.

@article{Foran1998HighdoseTW,
  title={High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre.},
  author={James M Foran and John Apostolidis and Dimitrios Papamichael and Andrew J. Norton and Janet M Matthews and J. A. L. Amess and T. Andrew Lister and Ama Z. S. Rohatiner},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={1998},
  volume={9 8},
  pages={865-9}
}
BACKGROUND The prognosis of patients with transformed follicular lymphoma (FL-t) is poor. The use of high-dose therapy (HDT) with autologous haematopoietic support was therefore evaluated as consolidation of remission. PATIENTS AND METHODS Twenty-seven patients received high-dose cyclophosphamide and total body irradiation (cyclo + TBI) with autologous bone marrow (BM; n = 24) or peripheral blood progenitor cell support (PBPC; n = 3). BM was treated in vitro with anti-B cell antibodies and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Chemosensitive transformed follicular non-Hodgkin's lymphoma is a firm indication for high-dose therapy and autologous stem cell transplantation. A study from the EBMT registry

  • CD Williams, G Taghipour, TA Lister
  • (Proc Am Soc Hematol) Blood
  • 1996
2 Excerpts

progenitor cell transplantation in 60 patients with poor - prognosis follicular lymphoma

  • AR Yuen, OW Kamel, J Halpern, SJ Horning
  • 1995

Similar Papers

Loading similar papers…